May 31, 2019
Teva Takeda Yakuhin said on May 30 that it has initiated a partial voluntary recall of its osteoporosis treatment Menatetrenone Capsules 15 mg “TYK” after some products failed in a purity test conducted as part of a long-term stability study...read more